FRANKFURT: German pharmaceuticals maker Merck KGaA said on Wednesday it is sticking to its full-year forecasts, despite a drop in earnings in the second quarter.
"We had a solid second quarter," said chief executive Karl-Ludwig Kley.
"This was primarily due to our healthy operating business. Especially in emerging markets, all our divisions performed well."
In the period from April to June, bottom-line net profit fell by 4.0 percent to 303 million euros ($405 million) and underlying profit was down 3.3 percent at 767 million euros.
Second-quarter revenues grew by 0.8 percent to 2.863 billion euros.
"Owing to our business performance in the first half of 2014, we confirm our forecast for the full year," Merck said.
Overall sales would amount to 10.9-11.1 billion euros and operating profit would total 3.3-3.4 billion euros.
Comments
Comments are closed.